Estimated Revenue & Valuation
- uMotif's estimated annual revenue is currently $25.1M per year.
- uMotif's estimated revenue per employee is $282,135
Employee Data
- uMotif has 89 Employees.
- uMotif grew their employee count by 3% last year.
uMotif Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $25.9M | 79 | 16% | N/A | N/A |
#2 | $34.6M | 106 | -8% | N/A | N/A |
#3 | $54.4M | 151 | -1% | N/A | N/A |
#4 | N/A | 0 | N/A | N/A | N/A |
#5 | $25.1M | 89 | 3% | £8.2M | N/A |
#6 | $8.2M | 31 | -21% | N/A | N/A |
#7 | $21.3M | 65 | 3% | N/A | N/A |
#8 | $133.7M | 327 | 5% | N/A | N/A |
#9 | $142.4M | 349 | 18% | N/A | N/A |
#10 | $105M | 257 | 11% | N/A | N/A |
What Is uMotif?
uMotif is the leading modern data capture platform for research, that patients love to use. With industry leading expertise in Real World and non-interventional studies, the engaging and clinically-proven platform captures e-consent, eCOA / ePRO, symptom and wearable device data. Working with top pharma, CROs and e-clinical platforms, uMotif can be deployed quickly across the world in any condition. uMotif is part of the Journal of mHealth's 2017 Digital Health 100.
keywords:N/AN/A
Total Funding
89
Number of Employees
$25.1M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
uMotif News
AlbionVC has led a £5 million Series A for uMotif, the London-based developer of an app that records and measures patients' health during clinical trials. The capital will go toward its international expansion and the development of new study designs. View details
London-based uMotif, a software that captures patient data for clinical studies, has raised £5 million in a Series A round led by existing investor AlbionVC, with participation from Norwegian firm DNV GL and angel investors. By creating a more engaging experience for study participants, uMotif ...
London-based uMotif – the patient-centric data capture software company has raised £5 million in a Series A investment round led by existing investor AlbionVC. The funding, which also saw participation from Oslo-based DNV-GL and existing angel investors, will accelerate uMotif’s growth and will ...
Exscientia, Science 37, Transparency Life Sciences, and uMotif IBM Corporation, Accenture PLC, AT&T Inc., CGI Group Inc., Syntel Inc. and ...
Patient-facing clinical trial software company uMotif has raised $3.2 million (£2.4 million) in a new funding round led by independent investment ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.7M | 89 | 16% | N/A |
#2 | $30.5M | 89 | -18% | $25.2M |
#3 | $24.3M | 89 | 2% | N/A |
#4 | $21.6M | 89 | 37% | N/A |
#5 | $27.9M | 89 | 35% | N/A |